Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Cephalon chairman takes leave of absence

September 2, 2010 Research and Development, Sales and Marketing Cephalon, appointment, research and development, sales and marketing

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect. The company …
Appointment

Lung cancer vaccine poised to begin phase IIb/III trials

September 1, 2010 Research and Development NSCLC, TG4010, Transgene, cancer vaccine

French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …
News

Eye treatment could be commercial breakthrough for ThromboGenics

September 1, 2010 Research and Development ThromboGenics, eye care, microplasmin

Belgian biopharma company ThromboGenics could have a major product on its hands in the shape of new eye treatment. The …
News
Pandemrix pack

EMA to assess GSK flu vaccine for narcolepsy link

September 1, 2010 Research and Development, Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1

The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …
News

Pharma and the iPhone: there’s an app for that

September 1, 2010 Medical Communications, Research and Development, Sales and Marketing ipad, iphone

The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …
Feature

Talking R&D: Strategic vs full service CRO

September 1, 2010 Research and Development CRO, Talking Point, Talking R&D

CRF Health’s Greg Jewett and Medpace’s Alita Hassan debate the merits of a strategic or a full service contract research …
Feature
Roche building

Roche coy on job cut reports

September 1, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …
News

Kendle appoints Mark Roseman chief marketing officer

September 1, 2010 Research and Development Kendle, appointment, research and development

Mark Roseman has joined clinical research organisation Kendle as senior vice president and chief marketing officer. He has more than …
Appointment

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …
News

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2

August 26, 2010 Research and Development Kinapse, White paper, life sciences, pharma

With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
Feature
White paper

Roche signs $1bn peptide deal with Aileron

August 25, 2010 Research and Development, Sales and Marketing Aileron, Roche, peptide, stapled peptide therapeutics

Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …
News

Sutent disappoints in lung cancer

August 24, 2010 Research and Development, Sales and Marketing NSCLC, Pfizer, Sutent, Tarceva

Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …
News

GSK shingles vaccine enters late stage trials

August 23, 2010 Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …
News
Roche

Roche to acquire digital pathology specialists

August 23, 2010 Research and Development, Sales and Marketing Diagnostics, Roche

Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …
News
ASCO

ASCO 2010: The Hedgehog Pathway and other ways to target cancer

August 19, 2010 Research and Development ASCO, Cancer, thyroid cancer

The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …
Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026